![]() N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(N-ethylcyclopropanecarboxamido)-4-methyl-4′-morpholino-[1,1′-biphenyl]-3-carboxamide结构式
![]() |
常用名 | N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(N-ethylcyclopropanecarboxamido)-4-methyl-4′-morpholino-[1,1′-biphenyl]-3-carboxamide | 英文名 | N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(N-ethylcyclopropanecarboxamido)-4-methyl-4′-morpholino-[1,1′-biphenyl]-3-carboxamide |
---|---|---|---|---|
CAS号 | 2238820-26-1 | 分子量 | 542.67 | |
密度 | N/A | 沸点 | N/A | |
分子式 | C32H38N4O4 | 熔点 | N/A | |
MSDS | N/A | 闪点 | N/A |
用途N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(N-ethylcyclopropanecarboxamido)-4-methyl-4′-morpholino-[1,1′-biphenyl]-3-carboxamide 是一种强效的、选择性的Enhancer of Zeste Homolog 2 (EZH2),对EZH2 WT 和EZH2-Y641F 的IC50分别为37.6nM 和79.1nM。 |
英文名 | N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(N-ethylcyclopropanecarboxamido)-4-methyl-4′-morpholino-[1,1′-biphenyl]-3-carboxamide |
---|
描述 | N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(N-ethylcyclopropanecarboxamido)-4-methyl-4′-morpholino-[1,1′-biphenyl]-3-carboxamide 是一种强效的、选择性的Enhancer of Zeste Homolog 2 (EZH2),对EZH2 WT 和EZH2-Y641F 的IC50分别为37.6nM 和79.1nM。 |
---|---|
体外研究 | N-(4,6-二甲基-2-氧代-1,2-二氢吡啶-3-基)甲基)-5-(N-乙基环丙烷甲酰胺)-4-甲基-4′-吗啉基-[1,1′-联苯基]-3-甲酰胺对WSU-DLCL2细胞系具有抗增殖作用,GI50为0.2μM。 |
参考文献 | 1. Zhou B, et al. Discovery of IHMT-EZH2-115 as a Potent and Selective Enhancer of Zeste Homolog 2 (EZH2) Inhibitor for the Treatment of B-Cell Lymphomas. J Med Chem. 2021 Oct 28;64(20):15170-15188. |
分子式 | C32H38N4O4 |
---|---|
分子量 | 542.67 |